Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00322868
Status:
COMPLETED
Last Update Posted:
2018-02-23
First Post:
2006-05-04
Brief Title:
Safety and Efficacy of Pioglitazone as an Anti-inflammatory for the Treatment of Cystic Fibrosis CF Lung Disease
Sponsor:
University Hospitals Cleveland Medical Center
Organization:
University Hospitals Cleveland Medical Center
Organization Data
Organization:
University Hospitals Cleveland Medical Center
Class:
OTHER
Study ID:
CFFTI-Pio001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospitals Cleveland Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Michael W Konstan
Responsible Party Title:
Professor of Pediatrics
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University Hospitals Cleveland Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Cystic Fibrosis Foundation | OTHER |